News
TLC
7.00
0.00%
0.00
Webull provides a variety of real-time TLC stock news. You can receive the latest news about Taiwan Liposome Company, Ltd.c through multiple platforms. This information may help you make smarter investment decisions.
About TLC
Taiwan Liposome Company, Ltd. is a Taiwan-based company principally engaged in the research and development and commercialization of lipid drug delivery systems. The Company is engaged in the development of special generic drugs, new formulas and new drugs using patents. The Company's therapeutic areas include pain management, eye diseases and cancer. Its anticancer medicine product named Lipo-Dox has been distributed in domestic and Asian markets.